Dev48
Language
  • About
  • Services
  • Industries
  • Technologies
  • Articles
  • Contacts
Book a call
    Home/Articles/Getinge announces departure of eric honroth president life science
Dev48
info@dev48.org+375 29 320-40-96WhatsApp@isky_by

© 2026 · All rights reserved.

Getinge announces departure of Eric Honroth, President Life Science

Фото: wal_172619 (Pixabay) — https://pixabay.com/photos/travel-flight-schedule-ad-plan-4865665/

Source: Getinge•October 7, 2026 at 04:50 PM

Getinge announces departure of Eric Honroth, President Life Science

Getinge today announced that Eric Honroth will resign as President Life Science and member of the Executive Team to accept an external opportunity.

Press release Gothenburg, Sweden, on October 7, 2026

Regulatory | 10/7/2026

Getinge today announced that Eric Honroth will resign as President Life Science and member of the Executive Team to accept an external opportunity.

“We are thankful for Eric’s important contributions to Getinge, first as President for North America Sales and later as President Life Science,” said Mattias Perjos, President & CEO at Getinge. “His leadership, commitment and clear strategic direction have helped strengthen the business and create a strong foundation for the future. I would like to sincerely thank Eric for our collaboration and wish him every success in his new role.”

Getinge has started the process of identifying a successor, evaluating internal and external candidates. Honroth will continue to serve in his current role until his departure on October 31, 2026. An internal leader has been identified and will serve as acting President Life Science beginning November 1.

Media contact:

Caroline Örmgård, Head of Media Relations Phone: +46 (0)10 335 0041 Email: caroline.ormgard@getinge.com

About Getinge With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.

You are now leaving Getinge.com. You may access content that is not managed by the Getinge team, in which case Getinge can not be held responsible for the content.

← All articles

What this article says

More in HealthTech & MedTech

All →
The Shift to Proactive Patient Management
Athenahealth

The Shift to Proactive Patient Management

GE HealthCare Foundation announces 2026 grants to expand maternal and pediatric care in underserved communities
Ge Healthcare

GE HealthCare Foundation announces 2026 grants to expand maternal and pediatric care in underserved communities

GE HealthCare introduces new Imaging 360 features to simplify protocol management and support radiology workflows
Ge Healthcare

GE HealthCare introduces new Imaging 360 features to simplify protocol management and support radiology workflows

OCCLUDE Registry at SIR - Obsidio Conformable
Boston Scientific

OCCLUDE Registry at SIR - Obsidio Conformable

Anatomy Animation Animation- Obsidio™ Conformable Embolic
Boston Scientific

Anatomy Animation Animation- Obsidio™ Conformable Embolic

Setup Video - Obsidio™ Conformable Embolic
Boston Scientific

Setup Video - Obsidio™ Conformable Embolic

More from Getinge

Getinge establishes Sustainable Financing Framework
Getinge

Getinge establishes Sustainable Financing Framework

Getinge appoints Stacy Beske as President Acute Care Therapies
Getinge

Getinge appoints Stacy Beske as President Acute Care Therapies

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction
Getinge

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027
Getinge

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance
Getinge

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call
Getinge

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call